Tag: EV-ICD
AtaCor Medical enrols first patients in ASCEND EV clinical study
AtaCor Medical has announced that it has initiated its ASCEND EV study—a prospective, non-randomised international study aiming to evaluate the safety and performance of...
Final results from Medtronic’s EV ICD pivotal trial demonstrate high ATP...
Medtronic recently shared long-term results from the global EV ICD pivotal trial, reinforcing the performance and safety of the company’s extravascular implantable cardioverter defibrillator...
Medtronic receives CE mark for EV-ICD device to treat “dangerous” heart...
Medtronic has received CE mark for the Aurora extravascular implantable cardioverter-defibrillator (EV-ICD) magnetic resonance imaging (MRI) SureScan device and Epsila EV MRI SureScan defibrillation...
ESC 2022: Favourable results for Medtronic’s EV ICD system in pivotal...
Medtronic has announced that its investigational EV ICD system—a defibrillator with the lead placed under the breastbone, outside of the heart and veins—achieved a...
Medtronic begins pilot study of investigational extravascular ICD system
Medtronic plc have announced the start of a pilot study of its investigational extravascular implantable cardioverter defibrillator (EV ICD) system, in which a lead...
Study confirms feasibility of new extravascular approach to ICD therapy
Results from a research study demonstrating the feasibility of a novel approach to delivering pacing and defibrillation therapy in which a lead is placed...